A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With Depression

NCT00429260 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
125
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi